Nestlé H1 2026: Organic Growth Rises, Net Profit Drops 31.4%, and a $5.6 Billion Waters JV Reshapes the Portfolio

However, foreign exchange headwinds of -6.2% more than offset the organic gains, pulling reported sales down 2.5% to CHF 43.1 billion (~$52.9 billion) . Net profit fell to CHF 3.5 billion, a decline of 31.4% compared to CHF 5.1 billion in H1 2025 . The drop reflected higher restructuring costs, asset write-downs, and unfavorable currency translation .

Underlying earnings per share rose 4% in constant currency, but fell 2.4% at actual exchange rates due to Swiss franc strength . Free cash flow strengthened to CHF 3.4 billion . Nestlé's underlying trading operating profit (UTOP) margin edged down 10 basis points to 16.4%, with gross margin contracting 20 basis points to 46.4% .

Emerging markets outperformed, and China stabilized after a period of inventory destocking . The infant formula recall, announced in January 2026, weighed on Q1 results but its impact was described as contained .

Restructuring Move 1: The $5.6 Billion Peranel Joint Venture

The most significant strategic announcement was the creation of Peranel, a 50/50 joint venture with U.S. private equity firm Platinum Equity, carving out Nestlé's Waters & Premium Beverages business . The new entity houses more than 30 brands sold in 120 countries, including Perrier (Source Perrier), S.Pellegrino, Acqua Panna, and Nestlé Pure Life .

• Enterprise value: €4.9 billion (~$5.6 billion) .
• Nestlé's cash proceeds: ~€3 billion (~CHF 2.8 billion) from selling a 50% stake .
• Structure: Peranel is a standalone 50/50 JV; Nestlé retains ownership of the other half .
• Closing: Expected in the first half of 2027, subject to regulatory approvals and employee consultation .

Note on the $5.6 billion figure: Multiple sources describe the JV's total enterprise value as ~$5.6 billion , while others frame Nestlé's cash proceeds (for the 50% stake) as ~$3.4 billion . There is no conflict — $5.6 billion is the total JV valuation, of which Nestlé sold half.

The deal is part of Navratil's strategy to slim the portfolio, reduce complexity, and sharpen focus on faster-growth categories .

Restructuring Move 2: Ice Cream Business — Held for Sale

In February 2026, Nestlé announced plans to divest its remaining in-house ice cream business, which had been described as "strong but small" and "a distraction" by the CEO . The unit has been classified as an asset held for sale and is expected to be sold to Froneri, an existing JV partner that already holds Nestlé's U.S. ice cream business (acquired for $4 billion in 2019) . This exit follows Navratil's strategic refocus on four core pillars: Coffee, Petcare, Nutrition, and Food & Snacks .

Restructuring Move 3: Vitamins, Minerals, and Supplements — Held for Sale

Alongside the ice cream exit, Nestlé classified its mainstream vitamins, minerals, and supplements (VMS) business as held for sale . The company initiated a strategic review of its VMS portfolio, including brands such as Nature's Bounty, Puritan's Pride, and its private-label U.S. operations, though Solgar and other premium brands were expected to remain . The VMS divestiture is part of the same portfolio-slimming initiative .

Restructuring Move 4: Fuel for Growth Cost-Savings Program — On Track

Nestlé's company-wide cost-efficiency program, launched in January 2026, is delivering ahead of plan. Cumulative savings reached CHF 1.7 billion, with an incremental CHF 600 million generated in H1 2026 . The full-year 2026 target is CHF 2.0 billion .

The program targets CHF 3.0 billion in procurement and operational efficiency savings by the end of 2027, covering procurement consolidation, organizational streamlining, standardization, and automation . Management described the program as "on track" and "slightly ahead of plan," freeing up resources for reinvestment in growth .

What It All Means

Nestlé's H1 2026 results show a company executing a deliberate transformation: underlying volumes are recovering (RIG accelerated for four consecutive quarters), cost savings are materializing, and the portfolio is being radically simplified. At the same time, currency pressures, restructuring charges, and higher input costs are punishing near-term reported earnings. The Peranel JV, ice cream exit, and VMS divestiture collectively mark the most significant portfolio reshaping in years, with Nestlé placing its bets on coffee, petcare, nutrition, and food & snacks.

For 2026, Nestlé guided for organic growth in the range of 3% to 4%, with the UTOP margin expected to improve versus 2025 .